Micronutrients decrease incidence of common infections in type 2 diabetic outpatients
Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue, Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue
Abstract
A randomized, double-blind, placebo-controlled trial was carried out to investigate the effects of micronutrients supplementation on immunity and the incidence of common infections in type 2 diabetic outpatients. A total of 196 type 2 diabetic outpatients were randomized to receive tablets of micronutrients (n=97) or placebo (n=99) for 6 months. Individualized dietary energy intake and daily physical activity were recommended. Anthropometric measurements, blood biochemical variables and the incidence of common infections were measured at baseline and at 6 months. Data on diet, exercise and infection (upper respiratory tract infection, skin infection, urinary and genital tract infections, other infections) were recorded 1 month before the study and every month during the study. Blood concentrations of total protein, iron (Fe), folic acid and hemoglobin increased and unsaturated iron-binding capacity(UIBC) levels were decreased in the micronutrients supplementation group compared to the placebo group at 6 months. Moreover, at 6 months, compared to the placebo group, the blood concentrations of IgE, CD4+, CD4+/CD8+, WBC, lymphocyte counts, basophilic leukocyte increased and CD8+ count decreased in the supplementation group, and the levels of IgA, IgM, IgG and complements C3 and C4 did not differ. The incidence of upper respiratory infection, whitlow, dermapostasis, vaginitis, urinary tract infection, gingivitis and dental ulcer were lower and body temperature and duration of fever greatly improved in the supplementation than the placebo group. These data indicated that supplementation of micronutrients might increase immune function and reduce the incidence of common infections in type 2 diabetic outpatients.
Source: PubMed
다가오는 임상 시험
-
Magnus MedicalCongressionally Directed Medical Research Programs모병
-
Nicholas ButowskiSiren Biotechnology아직 모집하지 않음신경교종 | 뇌종양 | 재발성 고등급 신경교종미국
-
State University of New York at Buffalo아직 모집하지 않음
-
Poitiers University Hospital아직 모집하지 않음
-
Assistance Publique - Hôpitaux de Paris아직 모집하지 않음
-
University of California, Irvine모병뇌암 | CNS 암 | 신경계 암 | 뇌전이암미국
-
Guangdong Raynovent Biotech Co., Ltd아직 모집하지 않음
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable Foundation모병
-
Shanghai General Hospital, Shanghai Jiao Tong University...아직 모집하지 않음
-
Sun Yat-sen University아직 모집하지 않음금연 | AI 에이전트 | Early-Stage Cancer
-
Affiliated Hospital of Nantong University아직 모집하지 않음